These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 6110656)

  • 1. Cholinergic rebound in neuroleptic withdrawal syndromes.
    Lieberman J
    J Clin Psychiatry; 1981 Apr; 42(4):179. PubMed ID: 6110656
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of cholinergic supersensitivity in the medical symptoms associated with withdrawal of antipsychotic drugs.
    Luchins DJ; Freed WJ; Wyatt RJ
    Am J Psychiatry; 1980 Nov; 137(11):1395-8. PubMed ID: 6108078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Acute recurrent dystonia secondary to neuroleptic suppression].
    Modrego Pardo P; Pérez Trullen JM
    Rev Clin Esp; 1997 Mar; 197(3):211-2. PubMed ID: 9273591
    [No Abstract]   [Full Text] [Related]  

  • 4. Neuroleptic withdrawal.
    Maisami M; Golant D
    J Am Acad Child Adolesc Psychiatry; 1991 Mar; 30(2):336. PubMed ID: 1673122
    [No Abstract]   [Full Text] [Related]  

  • 5. Rebound insomnia in neuroleptic drug withdrawal neurophysiologic characteristics.
    van Sweden B
    Pharmacopsychiatry; 1987 May; 20(3):116-9. PubMed ID: 2885865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholinergic rebounds and withdrawal syndromes.
    Pary RJ; Klontz W; Foxworth JM
    Am J Psychiatry; 1980 Feb; 137(2):261. PubMed ID: 7352599
    [No Abstract]   [Full Text] [Related]  

  • 7. Neuroleptic malignant syndrome related to a switch to perospirone and anticholinergic withdrawal.
    Tanii H; Fujita K; Okazaki Y
    Am J Psychiatry; 2006 Mar; 163(3):547-8. PubMed ID: 16513884
    [No Abstract]   [Full Text] [Related]  

  • 8. Neuroleptic malignant syndrome precipitated by haloperidol following clozapine discontinuation.
    Mendhekar DN; Jiloha RC
    Aust N Z J Psychiatry; 2005 Oct; 39(10):947-8. PubMed ID: 16168023
    [No Abstract]   [Full Text] [Related]  

  • 9. REM-latency in neuroleptic drug withdrawal. A case report.
    Van Sweden B
    Acta Psychiatr Belg; 1984; 84(3):235-9. PubMed ID: 6148841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroleptic malignant syndrome and clozapine withdrawal at the same time?
    Margetić B; Aukst-Margetić B
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):145-7. PubMed ID: 15610957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Changes in the number of benzodiazepine receptors in different parts of the brain of rats after neuroleptic withdrawal].
    Zharkovskiĭ AM; Zharkovskaia TA
    Biull Eksp Biol Med; 1984 Oct; 98(10):457-9. PubMed ID: 6149778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholinergic rebound in neuroleptic withdrawal syndromes.
    Lieberman J
    Psychosomatics; 1981 Mar; 22(3):253-4. PubMed ID: 6111828
    [No Abstract]   [Full Text] [Related]  

  • 13. Atypical antipsychotics: CATIE study, drug-induced movement disorder and resulting iatrogenic psychiatric-like symptoms, supersensitivity rebound psychosis and withdrawal discontinuation syndromes.
    Chouinard G; Chouinard VA
    Psychother Psychosom; 2008; 77(2):69-77. PubMed ID: 18230939
    [No Abstract]   [Full Text] [Related]  

  • 14. Recurrence of hyperglycemic-induced chorea-ballismus after haloperidol withdrawal.
    Kim YD; Kim JS; Song IU; Lee KS; Kim YI
    Can J Neurol Sci; 2011 Jul; 38(4):663. PubMed ID: 21672711
    [No Abstract]   [Full Text] [Related]  

  • 15. [The neuroleptic malignant syndrome].
    Duarte J; García Viejo MA; García Miguel FJ; Sempere AP
    Med Clin (Barc); 1994 Oct; 103(14):558. PubMed ID: 7799673
    [No Abstract]   [Full Text] [Related]  

  • 16. Clozapine in tardive Tourette syndrome.
    Jaffe E; Trémeau F; Sharif Z; Reider R
    Biol Psychiatry; 1995 Aug; 38(3):196-7. PubMed ID: 7578666
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of "addictive" to describe neuroleptic drugs.
    McCormick S
    Am J Psychiatry; 1989 Sep; 146(9):1239-40. PubMed ID: 2569841
    [No Abstract]   [Full Text] [Related]  

  • 18. Neuroleptic withdrawal with remitted schizophrenics: a naturalistic follow-up study.
    Nishikawa T; Hayashi T; Koga I; Uchida Y
    Psychiatry; 2007; 70(1):68-79. PubMed ID: 17492913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Late extrapyramidal hyperkinesis and neuroleptic withdrawal dyskinesia. Practical problems].
    Hoffmann C; Faust V
    Fortschr Med; 1983 Mar; 101(11):470-6. PubMed ID: 6133824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Atypical" neuroleptic malignant syndrome and the spectrum of malignant cerebrotoxic syndromes.
    Choi-Kain LW; Pope HG
    Harv Rev Psychiatry; 2007; 15(4):181-6. PubMed ID: 17687712
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.